Bioavailability Study of SPARC1210 and Reference1210 in Subjects With Metastatic Breast Cancer

NCT02136927 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

33

Enrollment

INDUSTRY

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: SPARC1210
DRUG: Reference1210

Sponsor

Sun Pharma Advanced Research Company Limited